Crossject successfully designs and develops innovative, needle-free, pre-filled, single-use injection systems for Intradermal, Subcutaneous and Intramuscular applications for pharmaceutical companies.

Public Health is central to our development strategy
Actively addressing needle phobia and needle-stick injury contamination issues and offering patients comfort and safety of use to promote self-injection and contribute to treatment compliance.

Proven technology and clinically proven device platform offering pharmaceutical and biotech companies product optimisation through improved ease of use, safety and flexibility.
A single technological platform that can be adapted to the Intradermal, Subcutaneous and Intramuscular injection of drugs of various viscosities and volumes ranging from 0.1 to 0.6 ml.

Client pharmaceutical and biotech companies are offered exclusive partnerships in a given field or therapeutic class.

Long-lasting and solid industrial partnerships
The rigorous selection of sector leaders guarantees us optimal technical solutions and top quality suppliers combining to assure robust development and supply of devices.

Stable and complementary shareholders
Industrial partners, financial investors and individuals who are all committed to the long-term development of Crossject.